1999 Jul 15 [updated 2020 May 7]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025.
PMID:20301650
Vosoritide treatment for children with hypochondroplasia: a phase 2 trial.
Dauber A, Zhang A, Kanakatti Shankar R, Boucher K, McCarthy T, Shafaei N, Seaforth R, Castro MG, Dham N, Merchant N.
Hypochondroplasia gain-of-function mutation in FGFR3 causes defective bone mineralization in mice.
Loisay L, Komla-Ebri D, Morice A, Heuzé Y, Viaut C, de La Seiglière A, Kaci N, Chan D, Lamouroux A, Baujat G, Bassett JHD, Williams GR, Legeai-Mallet L.
JCI Insight. 2023 Jun 22;8(12):e168796. doi: 10.1172/jci.insight.168796.
PMID:37345656
Extensive Limb Lengthening for Achondroplasia and Hypochondroplasia.
Paley D.
Children (Basel). 2021 Jun 24;8(7):540. doi: 10.3390/children8070540.
PMID:34202538
Hypochondroplasia.
Walker BA, Murdoch JL, McKusick VA, Langer LO, Beals RK.
Am J Dis Child. 1971 Aug;122(2):95-104. doi: 10.1001/archpedi.1971.02110020029001.